You have full text access to this OnlineOpen article

Expression and Cell Distribution of Group I and Group II Metabotropic Glutamate Receptor Subtypes in Taylor-type Focal Cortical Dysplasia

  1. Eleonora Aronica1,2,
  2. Jan A. Gorter2,3,
  3. Gerard H. Jansen4,
  4. Cees W. M. Van Veelen5,
  5. Peter C. Van Rijen5,
  6. Marja Ramkema1,
  7. Dirk Troost1

Article first published online: 9 JUN 2003

DOI: 10.1046/j.1528-1157.2003.54802.x

Issue

Epilepsia

Epilepsia

Volume 44, Issue 6, pages 785–795, June 2003

Additional Information

How to Cite

Aronica, E., Gorter, J. A., Jansen, G. H., Van Veelen, C. W. M., Van Rijen, P. C., Ramkema, M. and Troost, D. (2003), Expression and Cell Distribution of Group I and Group II Metabotropic Glutamate Receptor Subtypes in Taylor-type Focal Cortical Dysplasia. Epilepsia, 44: 785–795. doi: 10.1046/j.1528-1157.2003.54802.x

Author Information

  1. 1

    Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, Amsterdam;

  2. 2

    Stichting Epilepsie Instellingen Nederland, Heemstede;

  3. 3

    Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands;

  4. 4

    Department of (Neuro)Pathology, Ottawa Hospital, Ottawa, Ontario, Canada; and

  5. 5

    Department of Neurosurgery, University Medical Center Utrecht, The Netherlands

*Address correspondence and reprint requests to Dr. E. Aronica at Department of (Neuro) Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. E-mail: e.aronica@amc.uva.nl

  1. Accepted January 24, 2003.

Publication History

  1. Issue published online: 9 JUN 2003
  2. Article first published online: 9 JUN 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (416K)

REFERENCES

  • 1
    Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy: review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995;54: 137–53.
  • 2
    Crino PB, Miyata H, Vinters HV. Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol 2002;12: 212–33.
    Direct Link:
  • 3
    Taylor DC, Falconer MA, Bruton CJ, et al. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971;34: 369–87.
  • 4
    Vinters HV, Fisher RS, Cornford ME, et al. Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue. Childs Nerv Syst 1992;8: 8–17.
  • 5
    Palmini A, Gambardella A, Andermann F, et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995;37: 476–87.
    Direct Link:
  • 6
    Mattia D, Olivier A, Avoli M. Seizure-like discharges recorded in human dysplastic neocortex maintained in vitro. Neurology 1995;45: 1391–5.
  • 7
    Jacobs KM, Kharazia VN, Prince DA. Mechanisms underlying epileptogenesis in cortical malformations. Epilepsy Res 1999;36: 165–88.
  • 8
    Avoli M, Mattia D, Olivier A. A window on the physiopathogenesis of seizures in patients with cortical dysplasia. Adv Exp Med Biol 2002;497: 123–32.
  • 9
    Swann JW, Hablitz JJ. Cellular abnormalities and synaptic plasticity in seizure disorders of the immature nervous system. Ment Retard Dev Disabil Res Rev 2000;6: 258–67.
    Direct Link:
  • 10
    Jacobs KM, Gutnick MJ, Prince DA. Hyperexcitability in a model of cortical maldevelopment. Cereb Cortex 1996;6: 514–23.
  • 11
    Najm IM, Ying Z, Babb T, et al. Epileptogenicity correlated with increased N-methyl-d-aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 2000;41: 971–6.
    Direct Link:
  • 12
    DeFazio RA, Hablitz JJ. Alterations in NMDA receptors in a rat model of cortical dysplasia. J Neurophysiol 2000;83: 315–21.
  • 13
    Ying Z, Babb TL, Comair YG, et al. Induced expression of NMDAR2 proteins and differential expression of NMDAR1 splice variants in dysplastic neurons of human epileptic neocortex. J Neuropathol Exp Neurol 1998;57: 47–62.
  • 14
    Avoli M, Bernasconi A, Mattia D, et al. Epileptiform discharges in the human dysplastic neocortex: in vitro physiology and pharmacology. Ann Neurol 1999;46: 816–26.
    Direct Link:
  • 15
    Hablitz JJ, DeFazio RA. Altered receptor subunit expression in rat neocortical malformations. Epilepsia 2000;41: S82–5.
    Direct Link:
  • 16
    Crino PB, Duhaime AC, Baltuch G, et al. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 2001;56: 906–13.
  • 17
    Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992;258: 597–603.
  • 18
    Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995;34: 1–26.
  • 19
    Schoepp DD, Jane DE, Monn JA. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 1999;38: 1431–76.
  • 20
    Wong RK, Bianchi R, Taylor GW, et al. Role of metabotropic glutamate receptors in epilepsy. Adv Neurol 1999;79: 685–98.
  • 21
    Chapman AG. Glutamate receptors in epilepsy. Prog Brain Res 1998;116: 371–83.
  • 22
    Tizzano JP, Griffey KI, Schoepp DD. Induction or protection of limbic seizures in mice by mGluR subtype selective agonists. Neuropharmacology 1995;34: 1063–7.
  • 23
    Burke JP, Hablitz JJ. Modulation of epileptiform activity by metabotropic glutamate receptors in immature rat neocortex. J Neurophysiol 1995;73: 205–17.
  • 24
    Chapman AG, Nanan K, Williams M, et al. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology 2000;39: 1567–74.
  • 25
    Greenwood RS, Fan Z, McHugh R, et al. Inhibition of hippocampal kindling by metabotropic glutamate receptor antisense oligonucleotides. Mol Cell Neurosci 2000;16: 233–43.
  • 26
    Folbergrova J, Haugvicova R, Mares P. Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonists. Brain Res 2001;908: 120–9.
  • 27
    Moldrich RX, Beart PM, Jane DE, et al. Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice. Neuropharmacology 2001;40: 732–5.
  • 28
    Moldrich RX, Jeffrey M, Talebi A, et al. Anti-epileptic activity of group II metabotropic glutamate receptor agonists (–)-2 oxa-4-aminobicyclo(3.1.0)hexane-4,6-dicarboxylate (LY379268) and (–)-2-thia-4-aminobicyclo(3.1.0)hexane-4,6-dicarboxylate (LY389795). Neuropharmacology 2001;41: 8–18.
  • 29
    Merlin LR. Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. J Neurophysiol 2002;87: 621–5.
  • 30
    Van Veelen CW, Debets RM, Van Huffelen AC, et al. Combined use of subdural and intracerebral electrodes in preoperative evaluation of epilepsy. Neurosurgery 1990;26: 93–101.
  • 31
    Engel JJ. Outcome with respect to epileptic seizures. In: EngelJEJr, ed. Surgical treatment of epilepsy. New York : Raven Press, 1987: 553–71.
  • 32
    Aronica E, Catania MV, Geurts J, et al. Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience 2001;105: 509–20.
  • 33
    Aronica E, Yankaya B, Jansen GH, et al. Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. Neuropathol Appl Neurobiol 2001;27: 223–37.
    Direct Link:
  • 34
    Romijn HJ, Uum JF, Breedijk I, et al. Double immunolabeling of neuropeptides in the human hypothalamus as analyzed by confocal laser scanning fluorescence microscopy. J Histochem Cytochem 1999;47: 229–36.
  • 35
    Khurgel M, Ivy GO. Astrocytes in kindling: relevance to epileptogenesis. Epilepsy Res 1996;26: 163–75.
  • 36
    Aronica E, Van Vliet EA, Mayboroda OA, et al. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci 2000;12: 2333–44.
    Direct Link:
  • 37
    Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002;125: 1719–32.
  • 38
    Ong WY, He Y, Tan KK, et al. Differential localisation of the metabotropic glutamate receptor mGluR1a and the ionotropic glutamate receptor GluR2/3 in neurons of the human cerebral cortex. Exp Brain Res 1998;119: 367–74.
  • 39
    Oka A, Takashima S. The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains. Acta Neuropathol (Berl) 1999;97: 275–8.
  • 40
    Tang FR, Lee WL, Yeo TT. Expression of the group I metabotropic glutamate receptor in the hippocampus of patients with mesial temporal lobe epilepsy. J Neurocytol 2001;30: 403–11.
  • 41
    Tang FR, Lee WL. Expression of the group II and III metabotropic glutamate receptors in the hippocampus of patients with mesial temporal lobe epilepsy. J Neurocytol 2001;30: 137–43.
  • 42
    Phillips T, Rees S, Augood S, et al. Localization of metabotropic glutamate receptor type 2 in the human brain. Neuroscience 2000;95: 1139–56.
  • 43
    Mizoguchi M, Iwaki T, Morioka T, et al. Abnormal cytoarchitecture of cortical dysplasia verified by immunohistochemistry. Clin Neuropathol 1998;17: 10–9.
  • 44
    Babb TL, Ying Z, Hadam J, et al. Glutamate receptor mechanisms in human epileptic dysplastic cortex. Epilepsy Res 1998;32: 24–33.
  • 45
    Spreafico R, Battaglia G, Arcelli P, et al. Cortical dysplasia: an immunocytochemical study of three patients. Neurology 1998;50: 27–36.
  • 46
    Hilbig A, Babb TL, Najm I, et al. Focal cortical dysplasia in children. Dev Neurosci 1999;21: 271–80.
  • 47
    Merlin LR. Metabotropic glutamate receptors in the plasticity of excitatory responses in the hippocampus: clinical impact. Adv Exp Med Biol 1998;446: 131–44.
  • 48
    Merlin LR, Wong RK. Role of group I metabotropic glutamate receptors in the patterning of epileptiform activities in vitro. J Neurophysiol 1997;78: 539–44.
  • 49
    Merlin LR. Group I mGluR-mediated silent induction of long-lasting epileptiform discharges. J Neurophysiol 1999;82: 1078–81.
  • 50
    Takahashi H, Wakabayashi K, Kawai K, et al. Neuroendocrine markers in central nervous system neuronal tumors (gangliocytoma and ganglioglioma). Acta Neuropathol 1989;77: 237–43.
  • 51
    Jay V, Becker LE, Otsubo H, Hwang PA, et al. Pathology of temporal lobectomy for refractory seizures in children: review of 20 cases including some unique malformative lesions. J Neurosurg 1993;79: 53–61.
  • 52
    Prayson RA, Estes ML, Morris HH. Coexistence of neoplasia and cortical dysplasia in patients presenting with seizures. Epilepsia 1993;34: 609–15.
    Direct Link:
  • 53
    Zhu JJ, Leon SP, Folkerth RD, et al. Evidence for clonal origin of neoplastic neuronal and glial cells in gangliogliomas. Am J Pathol 1997;151: 565–71.
  • 54
    Blumcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 2002;61: 575–84.
  • 55
    Akbar MT, Rattray M, Powell JF, et al. Altered expression of group I metabotropic glutamate receptors in the hippocampus of amygdala-kindled rats. Brain Res Mol Brain Res 1996;43: 105–16.
  • 56
    Aronica EM, Gorter JA, Paupard MC, et al. Status epilepticus-induced alterations in metabotropic glutamate receptor expression in young and adult rats. J Neurosci 1997;17: 8588–95.
  • 57
    Blumcke I, Becker AJ, Klein C, et al. Temporal lobe epilepsy associated up-regulation of metabotropic glutamate receptors: correlated changes in mGluR1 mRNA and protein expression in experimental animals and human patients. J Neuropathol Exp Neurol 2000;59: 1–10.
  • 58
    Dietrich D, Kral T, Clusmann H, et al. Reduced function of L-AP4-sensitive metabotropic glutamate receptors in human epileptic sclerotic hippocampus. Eur J Neurosci 1999;11: 1109–13.
    Direct Link:
  • 59
    Neugebauer V, Keele NB, Shinnick-Gallagher P. Epileptogenesis in vivo enhances the sensitivity of inhibitory presynaptic metabotropic glutamate receptors in basolateral amygdala neurons in vitro. J Neurosci 1997;17: 983–95.
  • 60
    Tang E, Yip PK, Chapman AG, et al. Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats. Eur J Pharmacol 1997;327: 109–15.
  • 61
    Attwell PJ, Koumentaki A, Abdul-Ghani AS, et al. Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats. Brain Res 1998;787: 286–91.
  • 62
    Keele NB, Neugebauer V, Shinnick-Gallagher P. Differential effects of metabotropic glutamate receptor antagonists on bursting activity in the amygdala. J Neurophysiol 1999;81: 2056–65.
  • 63
    Anneser JM, Horstmann S, Weydt P, et al. Activation of metabotropic glutamate receptors delays apoptosis of chick embryonic motor neurons in vitro. Neuroreport 1998;9: 2039–43.
  • 64
    Copani A, Bruno V, Battaglia G, et al. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Mol Pharmacol 1995;47: 890–7.
  • 65
    Rosenow F, Luders HO, Dinner DS, et al. Histopathological correlates of epileptogenicity as expressed by electrocorticographic spiking and seizure frequency. Epilepsia 1998;39: 850–6.
    Direct Link:
  • 66
    Farrell MA, DeRosa MJ, Curran JG, et al. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol 1992;83: 246–59.
  • 67
    Wolf HK, Birkholz T, Wellmer J, et al. Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies. J Neuropathol Exp Neurol 1995;54: 689–97.
  • 68
    Miller S, Kesslak JP, Romano C, et al. Roles of metabotropic glutamate receptors in brain plasticity and pathology. Ann N Y Acad Sci 1995;757: 460–74.
    Direct Link:
  • 69
    Romano C, Sesma MCTM, O'alley K, et al. Distribution of metabotropic glutamate receptor mGluR immunoreactivity in rat brain. J Comp Neurol 1995;355: 455–69.
    Direct Link:
  • 70
    Ulas J, Satou T, Ivins KJ, et al. Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures. Glia 2000;30: 352–61.
    Direct Link:
  • 71
    Ferraguti F, Corti C, Valerio E, et al. Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp Brain Res 2001;137: 1–11.
  • 72
    Winder DG, Ritch PS, Gereau RW IV, et al. Novel glial-neuronal signalling by coactivation of metabotropic glutamate and beta-adrenergic receptors in rat hippocampus. J Physiol (Lond) 1996;494: 743–55.
  • 73
    Carmignoto G. Central role of neuron-to-astrocyte signalling in the control of brain microcirculation. Neuropharmacology 2002;43: 180.
  • 74
    Bruno V, Battaglia G, Casabona G, et al. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci 1998;18: 9594–600.
  • 75
    Ciccarelli R, Di Iorio P, Bruno V, et al. Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes. Glia 1999;27: 275–81.
    Direct Link:
  • 76
    Lee SH, Magge S, Spencer DD, et al. Human epileptic astrocytes exhibit increased gap junction coupling. Glia 1995;15: 195–202.
    Direct Link:
  • 77
    Attwell D. Glia and neurons in dialogue [news; comment]. Nature 1994;369: 707–8.
  • 78
    Parpura V, Basarsky TA, Liu F, et al. Glutamate-mediated astrocyte-neuron signalling [see comments]. Nature 1994;369: 744–7.
  • 79
    Ciccarelli R, Sureda FX, Casabona G, et al. Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and -5 on astrocyte proliferation in culture. Glia 1997;21: 390–8.
    Direct Link:
  • 80
    Gegelashvili G, Dehnes Y, Danbolt NC, et al. The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem Int 2000;37: 163–70.
  • 81
    Aronica E, Gorter JA, Ijlst-Keizers H, et al. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. European Journal of Neuroscience (in press).
View Full Article (HTML) Get PDF (416K)